Anagnostics Boosts Sales Force
News Feb 05, 2013
Karl Winkler (48) is another sales professional checking in at Anagnostics Bioanalysis GmbH (St. Valentin/NÖ).
Karl holds a sales diploma and worked for Heinen & Loewenstein - a medtech company - and for Messer Medical Austria.
In both positions he was responsible for the build-up of sales infrastructure and sales in Austria and abroad.
Karl Winkler worked already 20 years in sales and sales management, 11 years thereof in the medical field.
Karl’s field of excellence is drugs of abuse analytics. For the beginning he will focus on sales of drugs of abuse screening tests in German speaking countries (Germany, Austria, Switzerland).
Karl Winkler: “Anagnostics is a dynamic enterprise, which is now in the phase of market expansion. Our proprietary hybcell technology promises huge market potential and I am eager to contribute to the success of the company.”
Anagnostics Bioanalysis offers its innovative multiplexed diagnostics technology named hybcell technology in three areas: drugs of abuse screening for drug therapy, in the field of personalized medicine (companion diagnostics) and for integrated sepsis diagnostics.
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
New Blood Test Could Help Distinguish Heart Attack from Heart StrainNews
A new blood test developed by a UAlberta medical researcher is better at detecting damage to the heart caused by an actual heart attack. The test promises to improve how physicians diagnose and treat patients experiencing a possible heart attack.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018